Report on the event ‘Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem’, London, 8 November 2013

Author (Corporate)
Publisher
Publication Date 2013
Content Type

The European Medicines Agency (EMA), in collaboration with its EU and international partners, is involved in a number of initiatives attempting to limit the development of antimicrobial resistance.

This event brought together various EU and international stakeholders and decision-making factors and aimed to facilitate the discussion around the optimal ways in which the existing EU legislation with regard to medicinal products could be used to foster the development and approval of new antibiotics and to address antimicrobial resistance.
Source Link http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/12/WC500158230.pdf
Related Links
EMA: News, 12.12.13: EMA publishes report on workshop on regulatory options in the fight against antimicrobial resistance http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/12/news_detail_001988.jsp&mid=WC0b01ac058004d5c1
Subject Categories
Countries / Regions